Who gets Alzheimer?

['Umfweni ili ibula']

Ni bani abalwala ubulwele bwa Alzheimer?

Ubulwele bwa Alzheimer bulwele bwa kucefyako ubulwele bwa kuli bongobongo ubwikata sana abakalamba.

Ubulwele bwa Alzheimer bulakula nga tulekula, kabili bwaba sana ku bantu abali ne myaka ukucila pali 65.

Lelo, ubulwele bwa Alzheimer ubwatendeka bwangu kuti bwacitikila abantu abali ne myaka 30, 40, na 50, nangu ca kuti ubu tabuseeka sana.

Ulubuto lwa muntu e lulenga no bulwele bwa Alzheimer.

Abantu abakwata ulupwa abalwala ubu bulwele balaba na maka ya kulalwala.

Na kabili, utushiishi tumo pamo nga APOE-e4 kuti twalenga umuntu ukulwala ubulwele bwa Alzheimer.

Fimbi ifingalenga umuntu alwala ubulwele bwa Alzheimer ni fi: ukucenwa ku mutwe, ukulwala umutima, ukupeepa fwaka, ukufina sana, no kukanalatukusha umubili.

Cimo icacindama ca kuti nangu ca kuti kwaliba ifintu fimo ifingalenga umuntu ukulwala ubulwele bwa Alzheimer, ubu bulwele tabwisa pa mulandu wa bukote, kabili te bonse abakula abalwala ubu bulwele.

['Ifyebo Fimo']

PubMed/Medline https://www.nlm.nih.gov/databases/download/pubmed_medline.html

RefinedWeb https://arxiv.org/abs/2306.01116

Kovacs GG: Can Creutzfeldt-Jakob disease unravel the mysteries of Alzheimer? Prion. 2016, 10 (5): 369-376.

Cankurtaran M, Yavuz BB, Cankurtaran ES, Halil M, Ulger Z, Ariogul S: Risk factors and type of dementia: vascular or Alzheimer? Arch Gerontol Geriatr. , 47 (1): 25-34.

Mahami-Oskouei M, Hamidi F, Talebi M, Farhoudi M, Taheraghdam AA, Kazemi T, Sadeghi-Bazargani H, Fallah E: Toxoplasmosis and Alzheimer: can Toxoplasma gondii really be introduced as a risk factor in etiology of Alzheimer? Parasitol Res. 2016, 115 (8): 3169-74.

Vellas B, Andrieu S, Cantet C, Dartigues JF, Gauthier S: Long-term changes in ADAS-cog: what is clinically relevant for disease modifying trials in Alzheimer? J Nutr Health Aging. , 11 (4): 338-41.

Bakhtiari S, Moghadam NB, Ehsani M, Mortazavi H, Sabour S, Bakhshi M: Can Salivary Acetylcholinesterase be a Diagnostic Biomarker for Alzheimer? J Clin Diagn Res. 2017, 11 (1): ZC58-ZC60.

['Ukufumyamo: kwa cipatala']

['Iyi webusaiti yabelako ku kusambilisha fye abantu kabili te ya kubomfya pa kundapa.']

['Ifyebo fyaba pali iyi webusaiti tafifwile ukubomfiwa ku kwishiba ubulwele umuntu akwete nelyo ukuundapa ubulwele, kabili abafwaya ukupanda amano pa fya kundapwa bafwile ukuipusha badokota.']

['Moneni ukuti neural net iileasuka ifipusho, ilingi line tailondolola bwino bwino ifyebo, pamo nga impendwa ya bantu abalwala ubulwele bumo.']

['Lyonse muleipusha badokota nelyo ababomfi ba cipatala pa fyo mwingacita pa bumi bwenu. Mwilaleka ukumfwa ifyo badokota balanda pa mulandu wa fyebo mwabelenga pali iyi webusaiti. Nga mwamona ukuti namulwala ubulwele ubukalamba, mufwile ukwita bwangu ku cipatala. Iyi webusaiti nelyo ifyo mubomfya iyi webusaiti tafilenga mwaumfwana na badokota nelyo abalwele. BioMedLib na babomfi baiko, nelyo abaibikamo, tabapeelako uuli onse umulandu, nangu fye ni mu kulungatika nelyo mu kukanailanda, pa fyebo fyaba pali iyi webusaiti nelyo ifyo babomfya.']

['Ukufumyamo: insambu sha kulemba']

['Ifunde lya Digital Millennium Copyright Act ilya mu 1998, 17 U.S.C. § 512 (the DMCA) lyapeela inshila sha kupwishishamo ubwafya ku bene ba fipe abaishiba ukuti ifyebo fyaba pa Intaneti filatoba insambu shabo ukulingana ne funde lya U.S. pa fya mafunde ya kuicingilila. ']

['Nga mwamona ukuti ifyebo fimo nelyo ifintu fimbi ifyo babika pa webusaiti yesu nelyo pa milimo yesu fyalipula mu nsambu sha bene, imwe (nangu umwiminishi wenu) kuti mwatutumina kalata ya kutweba ukuti tufumye ifyo fyebo nelyo ifyo fintu, nelyo ukuti tuleke ukufibomfya. ']

['Ukutumina abantu amameseji pa Intaneti (moneni akabokoshi akaleti "Kutuminako Bamunyinefwe" pa kuti mwishibe ama adresi ya pa Intaneti) ].']

['Ifunde lya DMCA litila mu mashiwi ya musango wa kuti umuntu nacita ifyo mulefwaya, mufwile ukulembapo ifyebo pamo nga: (1) ifyo icitabo ico mulefwaya ukupeela abantu e co balefwaya ukupeela abantu; (2) ifyo icitabo ico mulefwaya ukupeela abantu e co balefwaya ukupeela abantu; (3) ifyo mwingatutumina ifyebo, pamo nga adresi yenu, inambala ya foni, e lyo na adresi ya e-mail; (4) ifyo mwingalanda ukuti mulesumina ukuti ifyo mulefwaya ukupeela abantu te fyo umwine wa ici citabo, nelyo umwiminishi wakwe, nelyo ifunde limbi lyalanda. ']

['(5) amashiwi yenu ayalembwa, aya kuti nga mwafilwa ukulemba, mukapeelwa umulandu wa bufi, ukuti ifyebo fyaba muli aya mashiwi fya cine kabili mwalikwata amaka ya kucingilila insambu sha bene isho mulefwaya ukufyenga; ']

['Kabili (6) ukusuminisha kwa mwine wa fipe nelyo ukwa muntu uwapeelwa insambu sha kucita ifintu pa mulandu wakwe. ']

['Nga tamulembele fyonse ifi, kuti mwafilwa ukubombelapo bwangu.']

['Ifya Kumfwana']

['Mukwai tumeni kalata ya ku email pa kwipusha icili conse nelyo ukutupeela amano.']

Who gets alzheimer?

Alzheimer's disease is a progressive neurodegenerative disorder that primarily affects older adults.

The risk of developing Alzheimer's disease increases with age, and it is most common in people over the age of 65.

However, early-onset Alzheimer's can occur in people in their 30s, 40s, and 50s, although this is less common.

Genetics also play a role in the development of Alzheimer's disease.

People with a family history of the disease are at a higher risk of developing it themselves.

Additionally, certain genetic mutations, such as the APOE-e4 gene, can increase the likelihood of developing Alzheimer's.

Other risk factors for Alzheimer's disease include a history of head injuries, cardiovascular disease, and lifestyle factors such as smoking, obesity, and lack of exercise.

It is important to note that while certain factors can increase the risk of developing Alzheimer's disease, it is not a normal part of aging, and not everyone who ages will develop the disease.

Disclaimer: medical

This web site is provided for educational and informational purposes only and does not constitute providing medical advice or professional services.

The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician.

Please note the neural net that generates answers to the questions, is specially inaccurate when it comes to numeric content. For example, the number of people diagnosed with a specific disease.

Always seek the advice of your doctor or other qualified health provider regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you think you may have a medical emergency, call 911 or go to the nearest emergency room immediately. No physician-patient relationship is created by this web site or its use. Neither BioMedLib nor its employees, nor any contributor to this web site, makes any representations, express or implied, with respect to the information provided herein or to its use.

Disclaimer: copyright

The Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (the “DMCA”) provides recourse for copyright owners who believe that material appearing on the Internet infringes their rights under U.S. copyright law. If you believe in good faith that any content or material made available in connection with our website or services infringes your copyright, you (or your agent) may send us a notice requesting that the content or material be removed, or access to it blocked. Notices must be sent in writing by email (see 'Contact' section for email address) . The DMCA requires that your notice of alleged copyright infringement include the following information: (1) description of the copyrighted work that is the subject of claimed infringement; (2) description of the alleged infringing content and information sufficient to permit us to locate the content; (3) contact information for you, including your address, telephone number and email address; (4) a statement by you that you have a good faith belief that the content in the manner complained of is not authorized by the copyright owner, or its agent, or by the operation of any law; (5) a statement by you, signed under penalty of perjury, that the information in the notification is accurate and that you have the authority to enforce the copyrights that are claimed to be infringed; and (6) a physical or electronic signature of the copyright owner or a person authorized to act on the copyright owner’s behalf. Failure to include all of the above information may result in the delay of the processing of your complaint.